CA2319426A1 - Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases - Google Patents

Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases Download PDF

Info

Publication number
CA2319426A1
CA2319426A1 CA002319426A CA2319426A CA2319426A1 CA 2319426 A1 CA2319426 A1 CA 2319426A1 CA 002319426 A CA002319426 A CA 002319426A CA 2319426 A CA2319426 A CA 2319426A CA 2319426 A1 CA2319426 A1 CA 2319426A1
Authority
CA
Canada
Prior art keywords
group
amino
alkoxy
hydroxy
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002319426A
Other languages
English (en)
French (fr)
Inventor
Kenichirou Kiyoshima
Yasuhiko Kawano
Yasuko Ashida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2319426A1 publication Critical patent/CA2319426A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002319426A 1998-03-04 1999-03-03 Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases Abandoned CA2319426A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5158398 1998-03-04
JP10/51583 1998-03-04
PCT/JP1999/001010 WO1999044611A1 (en) 1998-03-04 1999-03-03 Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases

Publications (1)

Publication Number Publication Date
CA2319426A1 true CA2319426A1 (en) 1999-09-10

Family

ID=12890971

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002319426A Abandoned CA2319426A1 (en) 1998-03-04 1999-03-03 Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases

Country Status (4)

Country Link
EP (1) EP1059924A1 (de)
AU (1) AU3274199A (de)
CA (1) CA2319426A1 (de)
WO (1) WO1999044611A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3200B (en) * 1992-03-18 1995-03-27 Takeda Chemical Industries Ltd Triazolopyridazine methodfor production thereof and use
TW304878B (de) * 1993-09-21 1997-05-11 Takeda Pharm Industry Co Ltd
ATE201875T1 (de) * 1994-09-16 2001-06-15 Takeda Chemical Industries Ltd Triazolopyridazine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
AU3274199A (en) 1999-09-20
WO1999044611A1 (en) 1999-09-10
EP1059924A1 (de) 2000-12-20

Similar Documents

Publication Publication Date Title
AU654430B2 (en) Triazolopyridazine compounds, their production and use
CN106132403B (zh) 喷雾干燥制剂
US20110207754A1 (en) Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
CA2054091A1 (en) Isoquinolinone derivatives
JP2002527473A (ja) フォルモテロールを含む貯蔵可能な活性物質濃縮物
JP2022532431A (ja) イマチニブ製剤、その製造および使用
CA3147105A1 (en) Combination of an a2-adrenoceptor subtype c (alpha-2c) antagonists with a task1/3 channel blocker for the treatment of sleep apnea
JP2001511792A (ja) 置換（１，３−ビス（シクロヘキシルメチル）−１，２，３，６−テトラヒドロ−２，６−ジオキソ−９ｈ−プリン−８−イル）フェニル誘導体、それらの調製、および炎症性疾患および免疫疾患の治療におけるそれらの使用
EP0620224B1 (de) Triazolopyridazin-Derivate, ihre Herstellung und Verwendung
EP4028131B1 (de) Heteroaromatische verbindungen, die nützlich in therapien sind
CA2319426A1 (en) Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases
EP0562440B1 (de) Imidazopyridazine als Antiasthmatika
DE69521209T2 (de) Triazolopyridazine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel
AU2021321705B2 (en) Novel cycloalkenone compound or salt thereof
JPH11315024A (ja) 気管支作用剤
JPS5823877B2 (ja) ナフチリジン誘導体およびその製造方法
EP0865790A2 (de) Verwendung von Triazolopyridazine Derivaten zur Herstellung eines Medikaments zur atopischen Dermatitisbehandlung
CA2544322C (en) Agent for treating chronic pelvic pain syndrome
CN100491378C (zh) 新的取代四环咪唑衍生物,其制备方法,包含它们的药物组合物及它们作为药物的用途
JPS62294614A (ja) ベンゾ〔ｃ〕〔１，６〕ナフチリジン誘導体からなる新規医薬組成物
NZ209405A (en) Heterocyclic oxamic acids and pharmaceutical compositions
CN116731017B (zh) 一种喹啉并哌啶类化合物及其制备方法与应用
WO2004087131A1 (ja) 鎮咳剤
JP2000063274A (ja) 喘息抑制用吸入剤
WO2024105168A1 (en) Novel combinations useful for the treatments of als

Legal Events

Date Code Title Description
FZDE Discontinued